Raniprime-50 Ranitidine 50 mg Injection

Get a Price/Quote

MOQ : 10 Pieces

Raniprime-50 Ranitidine 50 mg Injection Specification

Indication
Gastroesophageal reflux disease (GERD), Peptic ulcer, Zollinger-Ellison syndrome

Salt Composition
Ranitidine 50 mg

Dosage Form
Injection

Enzyme Types
Not applicable (this is not an enzymatic preparation)

Feature
Fast acting, reliable acid suppression, parenteral use

Ingredients
Ranitidine Hydrochloride, Water for injections, Buffering agents

Application
Used for reducing stomach acid, treatment of ulcers and reflux

Ph Level
Not specified, but generally formulated to be isotonic and compatible with intravenous administration

Physical Color/Texture
Clear, colorless to pale yellow liquid

Storage Instructions
Store below 25C, protect from light

Shelf Life
Typically 2 years (refer to packaging for expiry)

Strength
50 mg per 2 ml ampoule

Brand Name
Raniprime-50

Administration Route
Intravenous (IV) or Intramuscular (IM) injection

Pack Size
5 x 2 ml ampoules per box

Prescription Status
Prescription only medication

Marketed Countries
Canada, European Union, United Kingdom, United States, Australia (as illustrated)

Raniprime-50 Ranitidine 50 mg Injection About

Raniprime-50 Ranitidine 50 mg Injection is an in-demand solution for rapid, first-string management of GERD, peptic ulcers, and related acid disorders. Formulated for intravenous or intramuscular access, each 2 ml ampoule delivers a crackerjack dose of Ranitidine 50 mg in a clear, colorless to pale yellow liquid. This terrific medication, supplied in boxes of five ampoules, ensures reliable, fast-acting acid suppression for prescription use. Raniprime-50 is globally marketed across Canada, the EU, UK, US, and Australia, supported by a strong shelf life and strict storage requirements for optimal efficacy.

Key Features and Competitive Edge of Raniprime-50

Raniprime-50 Ranitidine 50 mg Injection is a terrific choice for healthcare providers requiring rapid and reliable acid suppression. Its fast-acting, parenteral formula is ideal for critical care and hospital environments where immediate response is essential. Used by first-string medical professionals worldwide, its competitive advantage lies in its broad indications, including GERD, peptic ulcers, and Zollinger-Ellison syndrome. Clinicians value its precision, safety profile, and compatibility for both intravenous and intramuscular administration.

Packaging, Certification, and Sample Policy of Raniprime-50

Raniprime-50 is supplied in secure packs of 5 x 2 ml ampoules, ensuring ease of charge for medical inventory. The product holds international certifications, reflecting compliance with stringent quality standards. For bulk proposals or supply requests, clients may inquire about sample availability; a standard proposal amount may apply. Packaging is robust for global distribution, and complete certification details are provided with each shipment, underscoring the manufacturer's commitment to consistent, reliable supply.

FAQ's of Raniprime-50 Ranitidine 50 mg Injection:

Q: How should Raniprime-50 Ranitidine 50 mg Injection be administered?

A: Raniprime-50 should be administered by a healthcare professional, either intravenously (IV) or intramuscularly (IM), as prescribed. The dosage and route depend on the specific medical indication and patient needs.

Q: What are the main benefits of using Raniprime-50 Injection?

A: Raniprime-50 offers terrific, rapid acid suppression for conditions like GERD, peptic ulcers, and Zollinger-Ellison syndrome, making it ideal for acute management where fast response is essential.

Q: When is Raniprime-50 indicated for use?

A: This first-string injection is indicated for the treatment of gastroesophageal reflux disease (GERD), peptic ulcer disease, and Zollinger-Ellison syndrome when oral administration is not feasible or rapid control is required.

Q: Where is Raniprime-50 currently available for supply?

A: Raniprime-50 is marketed in Canada, the European Union, United Kingdom, United States, and Australia, reflecting its in-demand and globally trusted status.

Q: What are the storage instructions for Raniprime-50 Injection?

A: The ampoules should be stored below 25C and protected from light to maintain efficacy. Always check packaging for expiration date and further handling details.

Q: What does the packaging of Raniprime-50 include?

A: Raniprime-50 comes in boxes containing five 2 ml ampoules each, with each ampoule carrying 50 mg Ranitidine. Packaging ensures stability and protection during transport and storage.

Tell us about your requirement